AlphaMark Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

AlphaMark Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-89	Closed	-$9K	–	627
2019 Q4	$9K	Sell	89 -15	-14%	-$1.68K	﹤0.01%	348
2019 Q3	$12K	Hold	104	–	–	0.01%	312
2019 Q2	$18K	Hold	104	–	–	0.01%	285
2019 Q1	$18K	Hold	104	–	–	0.01%	275
2018 Q4	$10K	Hold	104	–	–	﹤0.01%	315
2018 Q3	$18K	Hold	104	–	–	0.01%	298
2018 Q2	$15K	Buy	104 +15	+17%	+$2.13K	0.01%	327
2018 Q1	$10K	Hold	89	–	–	﹤0.01%	354
2017 Q4	$12K	Hold	89	–	–	﹤0.01%	332
2017 Q3	$9K	Hold	89	–	–	﹤0.01%	352
2017 Q2	$9K	Hold	89	–	–	﹤0.01%	360
2017 Q1	$11K	Hold	89	–	–	0.01%	330
2016 Q4	$10K	Hold	89	–	–	0.01%	317
2016 Q3	$12K	Hold	89	–	–	0.01%	235
2016 Q2	$8K	Hold	89	–	–	﹤0.01%	255
2016 Q1	$6K	Hold	89	–	–	﹤0.01%	253
2015 Q4	$6K	Hold	89	–	–	﹤0.01%	253
2015 Q3	$8K	Buy	+89	New	+$9.9K	﹤0.01%	233

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AlphaMark Advisors's GWPH Position: Q1 2020 in Review

AlphaMark Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 89 shares — an estimated $9K sold.

AlphaMark Advisors first reported a position in GWPH in Q3 2015 and held it in 18 quarters. The position peaked at $18K in Q2 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

AlphaMark Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
AlphaMark Advisors sold 89 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $9K.
AlphaMark Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 18 quarters.
AlphaMark Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18K in Q2 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on AlphaMark Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.